SANGAMO THERAPEUTICS, INC

SGMOQ · OTCM

CIK 1001233fmd_0PA2E3EMHH7T13ZPF8XFE3K3Q7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2009 to Mar 31, 2026, 65 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.